Mechanism of cholate uptake: NA+‐cotransport, but not cholate/OH− exchange

M. Sawkat Anwer – 1 November 1990 – The mechanism(s) and driving force(s) for hepatocellular uptake of the unconjugated bile acid cholate were investigated in isolated basolateral (sinusoidal) rat liver plasma membrane (blLPM) vesicles and in protein free liposomes. In blLPM vesicles both an inwardly directed Na+ gradient and a transmembrane pH difference (8.0 in/6.0 out) stimulated cholate uptake 2‐3‐fold above equilibrium uptake values (overshoot).

Antibodies to nuclear lamin C in chronic hepatitis delta virus infection

Józefa Wȩsierska‐Ga̧dek, Edward Penner, Eva Hitchman, Georg Sauermann – 1 November 1990 – Sera of patients with chronic hepatitis delta virus infection stained the nuclear periphery in indirect immunofluorescence. Using proteins of isolated nuclei, isolated nuclear matrices, the nuclear pore complexlamina fraction and purified lamins A and C as antigen source in immunoblotting experiments, nuclear lamin C was identified as the reactive antigen. Most sera tested (8 of 10) recognized nuclear lamin C exclusively, but not the nuclear lamins A and B.

Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver resections

Antonio Francavilla, Carmine Panella, Lorenzo Polimeno, Antonio Giangaspero, Vincenzo Mazzaferro, Chen‐En Pan, David H. Van Thiel, Thomas E. Starzl – 1 November 1990 – Thirteen patients who underwent 40% to 80% removal of their livers had blood samples drawn initially and daily on postoperative days 1 to 7. The enzyme marker of heightened polyamine metabolism, ornithine decarboxylase, and the indicator of DNA synthesis, thymidine kinase, were measured.

Impaired lipopolysaccharide‐inducible tumor necrosis factor production in vitro by peripheral blood monocytes of patients with viral hepatitis

Christian Müller, Christoph C. Zielinski – 1 November 1990 – We investigated lipopolysaccharide‐induced tumor necrosis factor production in vitro by peripheral blood monocytes from patients with various liver diseases.

Cytokeratins for probing cell lineage relationships in developing liver

V. J. Desmet, Peter van Eyken, Raf Sciot – 1 November 1990 – Immunohistochemistry with monoclonal anti‐cytokeratin antibodies has revealed the presence of cytokeratin 19 in embryonic and early fetal hepatocytes. With the differentiation of bile ducts at about the 10th week, cytokeratin 19 disappears from liver cells but remains in bile duct cells. This marks an important step in the organogenesis of the liver.

Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: A clinicopathological study of 145 patients examined at autopsy

Ian R. Wanless, Powers Peterson, Asha Das, John K. Boitnott, G. William Moore, Vincent Bernier – 1 November 1990 – The pathogenesis of portal hypertension arising in patients with myeloproliferative disorders has been difficult to understand because liver biopsy findings often show minimal changes. It has been suggested that increased splenic blood flow, hepatic infiltration with hematopoietic cells or sinusoidal fibrosis may be important.

Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection

Peter Karayiannis, John Saldanha, John Monjardino, Robert Goldin, Janice Main, Shashi Luther, Mark Easton, Antonio Ponzetto, Howard C. Thomas – 1 November 1990 – To assess the role of immunization against hepatitis delta antigen in the prevention of hepatitis delta virus infection, woodchuck carriers of woodchuck hepatitis virus were immunized with a 64 amino acid portion of hepatitis delta antigen from its N‐terminal region. The protein was expressed in Escherichia coli and contained a major immunogenic epitope.

Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

Ian R. Wanless, John S. Lentz – 1 November 1990 – Steatohepatitis (fatty liver hepatitis), histologically identical to alcoholic disease, occurs in some obese patients after jejunoileal bypass. A similar lesion occurs rarely in obese patients without bypass surgery, but the risk factors are poorly understood. Hepatic steatosis, steatohepatitis and fibrosis were sought in 351 apparently nonalcoholic patients at autopsy and various risk factors were evaluated. Incidence of steatosis and steatohepatitis correlated with the degree of obesity.

Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man

Philippe Marteau, Olivier Chazouiléres, Anne Myara, Raymond Jian, Jean‐Claude Rambaud, Raoul Poupon – 1 November 1990 – The effect of long‐term administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids was determined using the tauro 23 (75Se) selena‐25 homotaurocholic acid test in a controlled double‐blind study involving healthy subjects (n = 15). Subjects received placebo or 13 to 15 mg/kg/day ursodeoxycholic acid for 5 wk.

Subscribe to